Cargando…
Gender Differences in Diagnosis, Prevention, and Treatment of Cardiotoxicity in Cardio-Oncology
Gender differences exist throughout the medical field and significant progress has been made in understanding the effects of gender in many aspects of healthcare. The field of cardio-oncology is diverse and dynamic with new oncologic and cardiovascular therapies approved each year; however, there is...
Autores principales: | Simek, Shawn, Lue, Brian, Rao, Anjali, Ravipati, Goutham, Vallabhaneni, Srilakshmi, Zhang, Kathleen, Zaha, Vlad G., Chandra, Alvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457034/ https://www.ncbi.nlm.nih.gov/pubmed/36079097 http://dx.doi.org/10.3390/jcm11175167 |
Ejemplares similares
-
Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022) -
Cardiovascular disease and chimeric antigen receptor cellular therapy
por: Rao, Anjali, et al.
Publicado: (2022) -
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
por: Albini, Adriana, et al.
Publicado: (2010) -
Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
por: Porter, Charles, et al.
Publicado: (2022) -
Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy
por: Han, Xinqiang, et al.
Publicado: (2017)